135 related articles for article (PubMed ID: 18925667)
1. Pigmented villonodular synovitis in a patient with Noonan syndrome and SOS1 gene mutation.
Mascheroni E; Digilio MC; Cortis E; Devito R; Sarkozy A; Capolino R; Dallapiccola B; Ugazio AG
Am J Med Genet A; 2008 Nov; 146A(22):2966-7. PubMed ID: 18925667
[No Abstract] [Full Text] [Related]
2. Polyarticular pigmented villonodular synovitis associated with multiple congenital anomalies. A case of Noonan-like/multiple giant cell lesion syndrome.
Minisola G; Porzio V; Ceralli F; Grillo LR; Porzio F
Clin Exp Rheumatol; 1996; 14(2):207-10. PubMed ID: 8737730
[TBL] [Abstract][Full Text] [Related]
3. [A case of Noonan Syndrome with coeliac disease due to SOS1 mutation].
Carcavilla Urquí A; Santomé Collazo JL; Barrio Castellanos R; Ezquieta Zubicaray B
Med Clin (Barc); 2011 Nov; 137(14):666-7. PubMed ID: 21524768
[No Abstract] [Full Text] [Related]
4. SOS1 and PTPN11 mutations in five cases of Noonan syndrome with multiple giant cell lesions.
Beneteau C; Cavé H; Moncla A; Dorison N; Munnich A; Verloes A; Leheup B
Eur J Hum Genet; 2009 Oct; 17(10):1216-21. PubMed ID: 19352411
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery ectasia in Noonan syndrome: Report of an individual with SOS1 mutation and literature review.
Calcagni G; Baban A; De Luca E; Leonardi B; Pongiglione G; Digilio MC
Am J Med Genet A; 2016 Mar; 170(3):665-9. PubMed ID: 26686981
[TBL] [Abstract][Full Text] [Related]
6. [SOS1 mutation: a new cause of Noonan syndrome].
Serrano-Martín MM; Martínez-Aedo MJ; Tartaglia M; López-Siguero JP
An Pediatr (Barc); 2008 Apr; 68(4):365-8. PubMed ID: 18394382
[TBL] [Abstract][Full Text] [Related]
7. Variable phenotypic expression in a large Noonan syndrome family segregating a novel SOS1 mutation.
van Trier DC; Rinne T; Noordam K; Draaisma JM; van der Burgt I
Am J Med Genet A; 2017 Nov; 173(11):2968-2972. PubMed ID: 28884940
[TBL] [Abstract][Full Text] [Related]
8. [New findings in Noonan syndrome and Leopard syndrome: activating mutations in RAF-1 and SOS-1].
Dereure O
Ann Dermatol Venereol; 2008; 135(8-9):624-5. PubMed ID: 18789305
[No Abstract] [Full Text] [Related]
9. Severe hypertrophic cardiomyopathy in Noonan syndrome-consider sequencing genes encoding sarcomeric proteins.
McBride KL
Am J Med Genet A; 2013 Jan; 161A(1):230-1. PubMed ID: 23239527
[No Abstract] [Full Text] [Related]
10. Polyarticular pigmented villonodular synovitis in children: evidence for a genetic contribution.
Wendt RG; Wolfe F; McQueen D; Murphy P; Solomon H; Housholder M
J Rheumatol; 1986 Oct; 13(5):921-6. PubMed ID: 3820202
[TBL] [Abstract][Full Text] [Related]
11. SOS1: a new player in the Noonan-like/multiple giant cell lesion syndrome.
Hanna N; Parfait B; Talaat IM; Vidaud M; Elsedfy HH
Clin Genet; 2009 Jun; 75(6):568-71. PubMed ID: 19438935
[TBL] [Abstract][Full Text] [Related]
12. Joint involvement in Noonan syndrome. A retrospective paediatric descriptive study.
Le Quellec A; Edouard T; Audebert-Bellanger S; Pouzet A; Bourdet K; Colson C; Oriot C; Poignant S; Saraux A; Devauchelle-Pensec V
Joint Bone Spine; 2022 Jan; 89(1):105270. PubMed ID: 34534690
[TBL] [Abstract][Full Text] [Related]
13. A further patient with Noonan syndrome due to a SOS1 mutation and rhabdomyosarcoma.
Hastings R; Newbury-Ecob R; Ng A; Taylor R
Genes Chromosomes Cancer; 2010 Oct; 49(10):967-8. PubMed ID: 20607846
[No Abstract] [Full Text] [Related]
14. Ulerythema ophryogenes, a rarely reported cutaneous manifestation of noonan syndrome: case report and review of the literature.
Li K; Ann Thomas M; Haber RM
J Cutan Med Surg; 2013; 17(3):212-8. PubMed ID: 23673306
[TBL] [Abstract][Full Text] [Related]
15. Polyarticular Form of Pigmented Villonodular Synovitis. Radiation and Surgical Therapy: Long Term Follow-up.
Vavrík P; Jarosová K; Popelka S
Acta Chir Orthop Traumatol Cech; 2008 Oct; 75(5):392-5. PubMed ID: 19026195
[TBL] [Abstract][Full Text] [Related]
16. Co-occurring PTPN11 and SOS1 gene mutations in Noonan syndrome: does this predict a more severe phenotype?
Brasil AS; Malaquias AC; Wanderley LT; Kim CA; Krieger JE; Jorge AA; Pereira AC; Bertola DR
Arq Bras Endocrinol Metabol; 2010 Nov; 54(8):717-22. PubMed ID: 21340158
[TBL] [Abstract][Full Text] [Related]
17. Tumor spectrum in children with Noonan syndrome and SOS1 or RAF1 mutations.
Denayer E; Devriendt K; de Ravel T; Van Buggenhout G; Smeets E; Francois I; Sznajer Y; Craen M; Leventopoulos G; Mutesa L; Vandecasseye W; Massa G; Kayserili H; Sciot R; Fryns JP; Legius E
Genes Chromosomes Cancer; 2010 Mar; 49(3):242-52. PubMed ID: 19953625
[TBL] [Abstract][Full Text] [Related]
18. Cognitive profile of a child with SOS1 mutation in Noonan syndrome.
Martínez Planelló A; Sotillo M; Rodríguez-Santos F
Neurologia (Engl Ed); 2018 Mar; 33(2):137-138. PubMed ID: 26968820
[No Abstract] [Full Text] [Related]
19. Severe developmental delay and complete agenesis of corpus callosum in a Noonan syndrome patient with SOS1 mutation.
Samanta D
Acta Neurol Belg; 2016 Jun; 116(2):223-4. PubMed ID: 26280111
[No Abstract] [Full Text] [Related]
20. SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patients.
Swanson KD; Winter JM; Reis M; Bentires-Alj M; Greulich H; Grewal R; Hruban RH; Yeo CJ; Yassin Y; Iartchouk O; Montgomery K; Whitman SP; Caligiuri MA; Loh ML; Gilliland DG; Look AT; Kucherlapati R; Kern SE; Meyerson M; Neel BG
Genes Chromosomes Cancer; 2008 Mar; 47(3):253-9. PubMed ID: 18064648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
